证券记录 · 已归档季度
BLFS
BioLife Solutions, Inc. · Healthcare · Medical - Instruments & Supplies
11被追踪持有人
+1Δ持有人
11.70M持有股份
$252.03M报告持仓市值
+2新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +10.0% ·
股份流向 +2.4% ·
净新建仓位 +9.1%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 82 | +15 | 26.70M | $753.05M | +17 | −2 |
| Q1 2026 | 70 | -3 | 26.13M | $498.41M | +5 | −8 |
| Q4 2025 | 72 | -4 | 28.22M | $682.48M | — | −4 |
| Q3 2025 | 16 | +2 | 14.03M | $358.03M | +2 | — |
| Q2 2025 | 11 | +1 | 11.70M | $252.03M | +2 | −1 |
| Q1 2025 | 7 | -1 | 2.99M | $68.26M | — | −1 |
| Q4 2024 | 8 | +1 | 4.22M | $109.55M | +1 | — |
| Q3 2024 | 6 | 0 | 1.96M | $49.08M | +1 | −1 |
| Q2 2024 | 6 | — | 1.99M | $42.59M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 5.54M | — | $119.28M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (被动) | 5.54M | — | $119.28M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 5.54M | — | $119.28M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 5.54M | — | $119.28M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 5.54M | — | $119.28M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 5.54M | — | $119.28M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 5.54M | — | $119.28M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 5.54M | — | $119.28M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 5.54M | — | $119.28M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 5.54M | — | $119.28M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (被动) | 5.54M | — | $119.28M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (被动) | 5.54M | — | $119.28M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (被动) | 5.54M | — | $119.28M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (被动) | 5.54M | — | $119.28M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | The Vanguard Group ✦ (被动) | 2.90M | — | $62.41M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | The Vanguard Group ✦ (被动) | 2.90M | — | $62.41M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | The Vanguard Group ✦ (被动) | 2.90M | — | $62.41M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | The Vanguard Group ✦ (被动) | 2.90M | — | $62.41M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (被动) | 2.90M | — | $62.41M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | State Street Global Advisors ✦ (被动) | 1.41M | -1.7% | $30.35M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Geode Capital Management ✦ (被动) | 921.11K | +3.8% | $19.84M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 22 | Geode Capital Management ✦ (被动) | 921.11K | +3.8% | $19.84M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | Citadel Advisors ✦ | 420.24K | +242.2% | $9.05M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | Citadel Advisors ✦ | 420.24K | +242.2% | $9.05M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | Renaissance Technologies ✦ | 306.10K | +551.3% | $6.59M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | D. E. Shaw & Co. ✦ | 115.71K | 新增 | $2.49M | 0.0% | New | 1 | SEC ↗ |
| 27 | Gotham Asset Management ✦ | 39.62K | 新增 | $853,479 | 0.0% | New | 1 | SEC ↗ |
| 28 | Millennium Management ✦ | 26.91K | -93.1% | $579,749 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 29 | T. Rowe Price ✦ | 24.06K | +15.0% | $519,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Fidelity (FMR) ✦ | 3.08K | — | $66,357 | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Fidelity (FMR) ✦ | 3.08K | — | $66,357 | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Fidelity (FMR) ✦ | 3.08K | — | $66,357 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| D. E. Shaw & Co. | $2.49M | 0.0% |
| Gotham Asset Management | $853,479 | 0.0% |
已清仓
| Point72 Asset Management | $2.01M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 186 持有人, 49.64M 股份, $817.90M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据